Global Nuclear Medicine Diagnostics Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 5.90 Billion |
 Market Size (Forecast Year) |
USD 13.21 Billion |
 CAGR |
% |
| Major Markets Players |
>全球核医学诊断市场，按类型（SPECT放射性药物、PET 放射性药物）、应用（SPECT 应用、PET 应用）、程序（中枢神经系统、内分泌、骨骼、胃肠道、泌尿生殖系统、肺部）、最终用户（医院和诊断中心、研究机构）划分 - 行业趋势和预测到 2029 年。
核医学诊断市场分析及规模
核医学广泛应用于癌症治疗和骨转移的放射性药物应用。与X射线和其他外部放射成像设备相比，它不仅对医生的诊断有用，而且对患者来说也是一种方便安全的替代方法。诊断程序中使用的核医学包括F-18、Tc-99、Ga-67和I-123，而治疗程序包括I-131、Ir-192、Y-90、I-125和Lu-177。
Data Bridge Market Research 分析认为，核医学诊断市场规模在 2021 年为 59 亿美元，到 2029 年将飙升至 132.1 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 10.60%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
核医学诊断市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
类型（SPECT 放射性药物、PET 放射性药物）、应用（SPECT 应用、PET 应用）、程序（中枢神经系统、内分泌、骨骼、胃肠道、泌尿生殖系统、肺部）、最终用户（医院和诊断中心、研究机构） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。 |
|
涵盖的市场参与者 |
Cardinal Health (U.S.), General Electric (U.S.), Lantheus (U.S.), Bayer AG (Germany), Bracco Diagnostic Inc. (Italy), NorthStar Medical Radioisotopes, LLC (U.S.), Eckert & Ziegler. (Germany), Jubilant DraxImage, Inc. (Canada), PharmaLogic Holdings Corp. (U.S.), Institute of Isotopes Co., Ltd (Hungary), SHINE Medical Technologies, LLC (U.S.), Global Medical Solutions LLC (China) |
|
Market Opportunities |
|
Market Definition
Nuclear medicine refers to a class of drugs that contain radioisotopes. They are unique medical products that contain radioisotopes and are used for diagnosis or treatment in critical clinical fields. Radiopharmaceuticals have recently emerged as one of the most effective technologies in a variety of fields, including neurology, cardiology, and oncology.
Global Nuclear Medicine Diagnostics Market Dynamics
Drivers
- Increasing demand of nuclear medicine diagnostics
The nuclear medicines diagnostics are mainly used in treatment of cancer such as in radiotherapy. According to GLOBOCAN 2021, 19.3 million new cancer cases were diagnosed worldwide in 2020, with the number expected to rise to 30.2 million cases by 2040. Furthermore, other factors, such as increasing SPECT and PET applications and growing public awareness of healthcare, are expected to drive the market during the forecast period.
- Rising demand of nuclear medicines in radiopharmaceutical applications
Nuclear medicine is used to detect heart disease and cancer. As these industries developed, some companies and investors are focusing on expanding the use of radiopharmaceuticals. The expansion of radiopharmaceutical applications has the potential to boost demand and acceptance during the forecast period.
Opportunities
- Launch of nuclear medicine centres
The launch of nuclear medicine centres around the world which will provide access to nuclear medicine treatments and create immense opportunity for the market growth. For instance, in May 2022, Penang Adventist Hospital (PAH), located in Pulau Pinang, Malaysia, will launch a full-fledged private nuclear medicine centre in northern Malaysia. The new facility provides diagnostic and treatment procedures for specific conditions and diseases such as hyperthyroidism, thyroid cancer, lymphomas, and bone pain caused by various types of cancer.
Restraints/Challenges
- High cost of nuclear medicine diagnostics
The stringent regulatory policies along with rising competition from conventional alternative will obstruct the market's growth rate. High cost of equipment and diagnostics which will become the biggest challenge for the growth of the market.
Furthermore, the desire for nuclear medicine is being hampered by isotope shortages and the possibility of traditional diagnostic tests.
本核医学诊断市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关核医学诊断市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
COVID-19 对核医学诊断市场的影响
COVID-19 疫情影响了全球核医学诊断。因此，医院扩大了检测能力，以通过预防病毒感染来挽救生命。由于 COVID-19 造成的财政困难，世界各国政府都在削减预算。疫情还减少了接受核医学手术的患者数量，取消了选择性治疗，并将医院置于行政控制之下。
最新动态
- 2022 年 3 月，槟城基督复临安息日会医院 (PAH) 宣布在马来西亚北部开设一家私人核医学设施。在当地市场，这一首次亮相预计将产生良好影响。然而，这些疗法的高昂价格可能会限制市场扩张，因为发展中国家的低收入人群可能无法负担这种治疗。
全球核医学诊断市场范围
核医学诊断市场根据类型、应用、程序和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- SPECT 放射性药物
- PET 放射性药物
应用
- SPECT 应用
- PET 应用
程序
- 中枢神经系统
- 内分泌
- 骨骼
- 胃肠道
- 泌尿生殖系统
- 肺部
最终用户
- 医院和诊断中心
- 研究机构
核医学诊断市场区域分析/见解
对核医学诊断市场进行了分析，并按国家、类型、应用、程序和最终用户提供了市场规模见解和趋势。
核医学诊断市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于研发活动的投资水平不断上升，北美在核医学诊断市场占据主导地位。
由于人们对核医学和分子成像认识的不断提高以及老年人口的增加，预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和核医学诊断市场份额分析
核医学诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对核医学诊断市场的关注有关。
核医学诊断市场的一些主要参与者包括：
- 康德乐 (美国)
- 通用电气（美国）
- Lantheus（美国）
- 拜耳公司（德国）
- 博莱科诊断公司（意大利）
- NorthStar Medical Radioisotopes, LLC（美国）
- 埃克特和齐格勒（德国）
- Jubilant DraxImage, Inc.（加拿大）
- PharmaLogic Holdings Corp.（美国）
- 匈牙利同位素研究所有限公司
- SHINE Medical Technologies, LLC（美国）
- 全球医疗解决方案有限责任公司 (中国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
